Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2011);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.583;Q1;210;18;59;2518;1400;59;23.81;139.89;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10.386;Q1;241;33;59;10674;1342;59;21.2;323.45;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;6.99;Q1;155;65;132;4358;1525;102;11.17;67.05;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;6.281;Q1;348;225;603;6565;6448;465;9.49;29.18;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.422;Q1;225;90;250;6986;2833;233;11.17;77.62;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;4.917;Q1;119;27;51;3149;622;50;10.49;116.63;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.88;Q1;331;114;406;14815;6127;359;11.72;129.96;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;4.19;Q1;233;297;913;27852;6805;901;6.84;93.78;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;4.15;Q1;227;254;808;17601;6518;772;7.82;69.3;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
10;12455;Molecular Therapy;journal;15250024, 15250016;3.46;Q1;185;275;791;10988;5393;694;6.78;39.96;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.411;Q1;211;101;300;18833;3008;297;9.65;186.47;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;26371;Natural Product Reports;journal;02650568, 14604752;3.285;Q1;188;82;218;15034;1969;209;9.13;183.34;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
13;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.242;Q1;134;24;83;4735;862;81;9.73;197.29;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;3.23;Q1;139;110;337;5553;2485;308;7.25;50.48;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
15;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;3.076;Q1;43;21;57;544;318;57;5.58;25.9;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
16;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;2.943;Q1;66;0;5;0;48;5;0;0;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.882;Q1;190;206;489;7558;2304;443;4.51;36.69;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;23010;Journal of Controlled Release;journal;18734995, 01683659;2.763;Q1;282;546;1042;17189;7324;969;6.05;31.48;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
19;4400151524;Particle and Fibre Toxicology;journal;17438977;2.76;Q1;105;34;94;1594;794;90;8.83;46.88;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
20;18148;Pain;journal;18726623, 03043959;2.74;Q1;269;451;1160;18754;6514;907;5.09;41.58;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.523;Q1;269;926;2467;31412;13378;2322;5.22;33.92;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.518;Q1;202;224;854;9009;4528;853;5.35;40.22;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
23;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.513;Q1;146;114;404;5746;2005;382;4.63;50.4;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.457;Q1;122;68;193;6372;1429;180;6.55;93.71;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2.351;Q1;138;248;520;12378;3252;505;5.47;49.91;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
26;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.341;Q1;203;562;1565;14529;7482;1220;4.75;25.85;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
27;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.295;Q1;177;299;899;12044;5189;894;5.34;40.28;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
28;20435;Neuropharmacology;journal;00283908, 18737064;2.293;Q1;176;323;771;20594;3951;758;5.14;63.76;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
29;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.252;Q1;276;703;2440;33350;14258;2436;5.61;47.44;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
30;24749;Addiction Biology;journal;13556215, 13691600;2.171;Q1;83;63;146;3188;775;141;5.48;50.6;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
31;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.137;Q1;96;94;232;8928;1112;220;4.76;94.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
32;23916;Environmental Pollution;journal;02697491, 18736424;2.041;Q1;249;486;1463;23044;6274;1442;4.15;47.42;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
33;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.021;Q1;195;285;797;7608;3822;633;4.71;26.69;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;2.013;Q1;133;112;191;4788;1450;186;7.49;42.75;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
35;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.011;Q1;143;445;754;19771;3919;711;5.03;44.43;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
36;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.998;Q1;113;116;370;6709;1788;343;4.47;57.84;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
37;21782;Psychopharmacology;journal;00333158, 14322072;1.994;Q1;202;406;1000;24825;4628;966;4.29;61.15;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
38;16836;BMC Chemical Biology;journal;14726769;1.979;Q1;20;2;17;74;73;17;4.07;37;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q1); Molecular Medicine (Q1)"
39;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.962;Q1;115;109;387;4965;1817;383;5;45.55;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
40;26380;Drug and Alcohol Dependence;journal;03768716;1.956;Q1;173;301;771;13671;3253;741;3.77;45.42;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
41;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.939;Q1;117;36;125;5090;709;116;5.84;141.39;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
42;21196;Drug Discovery Today;journal;18785832, 13596446;1.928;Q1;185;139;444;8041;3010;410;6.51;57.85;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
43;25218;Toxicological Sciences;journal;10960929, 10966080;1.89;Q1;193;292;853;16284;4325;800;4.87;55.77;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
44;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.885;Q1;206;349;1137;20773;5950;1033;5.2;59.52;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
45;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.868;Q1;223;462;1638;29783;7668;1549;3.97;64.47;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
46;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.861;Q1;169;61;180;3425;1150;165;5.81;56.15;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
47;144771;Clinical Trials;journal;17407753, 17407745;1.859;Q1;67;83;204;1835;484;170;2.21;22.11;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
48;21237;Drug Safety;journal;01145916, 11791942;1.803;Q1;131;96;306;4277;1194;243;3.76;44.55;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
49;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.799;Q1;168;207;708;8000;3735;700;5.02;38.65;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
50;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.787;Q1;233;406;1385;15944;6224;1375;4.17;39.27;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.759;Q1;96;131;364;14869;1730;337;5.24;113.5;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
52;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.699;Q1;183;430;828;53487;4666;823;5.47;124.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
53;19600166302;Current Molecular Pharmacology;journal;18744702;1.689;Q1;42;18;64;2266;312;64;5.29;125.89;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
54;84948;Expert Opinion on Drug Delivery;journal;17425247;1.689;Q1;116;111;295;11234;1654;290;5.68;101.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
55;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.678;Q1;213;278;809;13435;4004;766;4.65;48.33;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
56;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.673;Q1;77;65;135;4095;607;126;4.73;63;United States;Northern America;Springer New York;2006-2021;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
57;5400152706;Nanotoxicology;journal;17435390, 17435404;1.654;Q1;94;61;91;2635;509;88;5.53;43.2;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
58;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.625;Q1;118;99;322;5365;1415;317;4.14;54.19;Netherlands;Western Europe;Elsevier;1990-2021;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
59;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.616;Q1;159;259;732;13647;2879;707;3.74;52.69;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
60;19617;Antiviral Research;journal;01663542, 18729096;1.616;Q1;134;181;459;7940;2221;454;4.89;43.87;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q1)"
61;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.608;Q1;163;233;705;12008;3253;673;4.05;51.54;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
62;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.601;Q1;175;292;972;15369;4568;944;4.87;52.63;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
63;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.598;Q1;182;294;907;9410;3809;905;4.18;32.01;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
64;4000148019;AAPS Journal;journal;15507416;1.588;Q1;118;62;230;2283;1131;224;5.28;36.82;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
65;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.575;Q1;94;112;352;10954;1334;348;4.11;97.8;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
66;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.565;Q1;81;0;215;0;996;203;4.73;0;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
67;25075;Ecotoxicology;journal;09639292, 15733017;1.542;Q1;97;203;378;9869;1423;376;2.59;48.62;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
68;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.541;Q1;109;142;487;11009;2248;471;4.87;77.53;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
69;21790;Antiviral Therapy;journal;20402058, 13596535;1.515;Q1;89;155;424;5436;1623;415;3.15;35.07;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
70;21165;PharmacoEconomics;journal;11707690, 11792027;1.515;Q1;104;84;285;3908;927;228;2.75;46.52;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
71;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.494;Q1;90;49;148;2213;712;144;4.71;45.16;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
72;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.493;Q1;229;680;1822;25249;8041;1805;3.92;37.13;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
73;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.49;Q1;96;67;195;1885;577;183;2.63;28.13;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
74;21169;Pharmacological Research;journal;10436618, 10961186;1.488;Q1;147;164;373;8777;1783;359;5.06;53.52;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
75;20051;BioDrugs;journal;11738804, 1179190X;1.486;Q1;71;48;120;2573;560;114;4.07;53.6;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.483;Q1;73;177;106;4595;356;105;3.36;25.96;United States;Northern America;American Chemical Society;2010-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
77;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.475;Q1;66;0;236;0;872;224;3.82;0;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
78;26512;Tetrahedron;journal;14645416, 00404020;1.473;Q1;226;1196;3799;59894;13156;3772;3.4;50.08;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
79;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.468;Q1;90;99;188;10725;769;168;4.03;108.33;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
80;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.466;Q1;97;71;295;2917;1081;293;3.64;41.08;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
81;20664;Current Drug Targets;journal;18735592, 13894501;1.461;Q1;107;193;419;21891;1595;379;3.71;113.42;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
82;18071;Neurotoxicity Research;journal;14763524, 10298428;1.439;Q1;78;97;202;6297;741;198;3.69;64.92;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
83;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.437;Q1;75;83;118;6890;556;110;4.45;83.01;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
84;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.423;Q1;79;0;406;0;1537;382;3.78;0;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
85;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.414;Q1;166;405;1128;48213;4833;1016;4.18;119.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
86;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.413;Q1;186;478;1227;19675;4538;1182;3.48;41.16;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
87;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.405;Q1;91;167;435;11738;1669;350;3.87;70.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
88;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.395;Q1;100;38;89;4163;449;85;5;109.55;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
89;23053;Journal of Natural Products;journal;01633864, 15206025;1.384;Q1;147;397;1240;12192;4221;1217;3.47;30.71;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
90;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.354;Q1;129;113;335;5277;868;329;2.2;46.7;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
91;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.351;Q1;122;229;445;24674;1898;377;3.84;107.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
92;22072;Current Gene Therapy;journal;18755631, 15665232;1.347;Q1;75;50;132;6077;656;123;3.87;121.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
93;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.341;Q1;100;114;262;10207;936;234;3.13;89.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
94;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.337;Q1;134;292;937;18526;2932;702;2.79;63.45;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
95;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.326;Q1;89;24;80;3831;420;75;5.19;159.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
96;24763;Addictive Behaviors;journal;03064603;1.316;Q1;135;236;563;8254;1560;562;2.57;34.97;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
97;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.315;-;144;112;332;4614;1393;327;3.96;41.2;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
98;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.313;Q1;83;98;247;4811;783;244;2.97;49.09;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
99;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.312;Q1;91;141;459;11869;1830;452;4.31;84.18;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
100;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.309;Q1;82;94;102;7032;444;97;3.5;74.81;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
101;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1.285;Q1;78;44;143;1686;534;129;3.21;38.32;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
102;25219;Toxicology;journal;0300483X, 18793185;1.273;Q1;165;210;750;10076;3120;721;4.07;47.98;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
103;4400151608;ChemMedChem;journal;18607187, 18607179;1.267;Q1;106;235;640;9505;2246;626;3.27;40.45;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
104;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.263;Q1;120;257;1030;11395;2546;760;2.25;44.34;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
105;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.261;Q1;66;70;264;1568;541;166;1.97;22.4;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
106;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.242;Q1;144;191;504;7465;1995;498;3.75;39.08;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
107;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.228;Q1;39;19;60;562;133;54;2.62;29.58;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
108;18073;NeuroToxicology;journal;18729711, 0161813X;1.225;Q1;122;123;408;6479;1506;392;3.32;52.67;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
109;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.22;Q1;153;240;706;8650;2287;539;3.03;36.04;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
110;26514;Tetrahedron Letters;journal;00404039, 18733581;1.217;Q1;173;1736;5369;60571;16030;5368;3.01;34.89;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
111;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.215;Q1;205;757;1424;30232;5773;1414;3.62;39.94;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
112;17067;Phytomedicine;journal;09447113, 1618095X;1.215;Q1;127;200;505;6550;1982;499;3.83;32.75;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
113;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.214;Q1;95;43;163;2611;478;163;2.66;60.72;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
114;21167;Pharmacogenomics;journal;14622416, 17448042;1.213;Q1;94;164;556;8344;2043;456;3.44;50.88;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
115;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.211;Q1;145;332;200;1316;908;198;2.97;3.96;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Biomaterials (Q2); Nanoscience and Nanotechnology (Q2)"
116;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.194;Q1;121;166;501;10159;1615;451;3.17;61.2;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
117;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.191;Q1;133;490;1328;13994;4664;1317;3.36;28.56;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
118;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.181;Q1;121;178;449;5567;1560;428;3.19;31.28;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
119;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.163;Q1;72;81;143;2755;421;143;2.58;34.01;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
120;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.16;Q1;88;231;252;21146;898;230;3.14;91.54;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
121;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;1.15;Q1;73;31;127;1199;358;115;2.34;38.68;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
122;16088;Journal of Nanobiotechnology;journal;14773155;1.142;Q1;84;57;58;2106;277;58;4.11;36.95;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
123;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.138;Q1;139;268;746;16615;2287;741;2.83;62;United States;Northern America;Elsevier Inc.;1973-2021;"Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2)"
124;24028;Reproductive Toxicology;journal;08906238, 18731708;1.138;Q1;117;140;371;6399;1355;347;3.45;45.71;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
125;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.137;Q1;171;787;2773;30152;9142;2765;3.2;38.31;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
126;25240;Toxicology Letters;journal;03784274, 18793169;1.133;Q1;150;293;798;12085;2936;774;3.39;41.25;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
127;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.129;Q1;77;112;329;9333;987;320;3.84;83.33;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
128;145164;Human Genomics;journal;14739542, 14797364;1.126;Q1;59;36;89;1912;257;75;3.01;53.11;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
129;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.124;Q1;183;501;1592;21016;5884;1561;3.54;41.95;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
130;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.122;Q1;154;1516;4384;40378;12597;4382;2.81;26.63;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
131;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.116;Q1;76;11;36;2405;147;36;3.39;218.64;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
132;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;1.1;Q1;2;0;10;0;3;10;0;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
133;18966;Mutagenesis;journal;02678357, 14643804;1.092;Q1;95;102;201;5209;782;191;3.21;51.07;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
134;24604;Archives of Toxicology;journal;14320738, 03405761;1.084;Q1;121;160;321;8261;1317;282;4.12;51.63;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
135;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.071;Q1;114;356;812;11313;2550;797;3.04;31.78;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
136;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.071;Q1;70;49;106;1963;332;106;3.13;40.06;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
137;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.066;Q2;103;119;302;4362;900;276;3.24;36.66;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q2)"
138;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.066;Q1;78;98;318;2390;701;297;2.12;24.39;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
139;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.059;Q2;115;144;502;6438;1152;502;2.18;44.71;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q2)"
140;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;1.059;Q2;113;101;400;5410;1226;395;2.95;53.56;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
141;19427;Advances in Pharmacology;journal;15578925, 10543589;1.058;Q1;78;30;73;4440;194;26;2.82;148;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
142;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.058;Q1;189;802;2176;35013;7021;2171;2.9;43.66;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
143;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.047;Q1;114;185;519;5482;1579;445;2.81;29.63;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
144;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.043;Q1;175;672;1708;26078;6804;1707;3.86;38.81;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Organic Chemistry (Q2)"
145;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;1.033;Q1;93;116;351;5545;1026;351;2.76;47.8;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
146;4400151410;Human Vaccines;journal;15548600, 15548619;1.027;Q1;58;264;411;9869;1004;305;2.4;37.38;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
147;24652;Chemico-Biological Interactions;journal;00092797;1.019;Q2;128;199;872;8615;2868;852;3.23;43.29;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
148;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.019;Q1;140;229;809;7122;2448;719;2.71;31.1;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
149;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.018;Q1;88;120;369;11161;1486;365;3.5;93.01;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Toxicology (Q2)"
150;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.016;Q1;71;77;187;3384;486;154;2.84;43.95;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
151;20473;Life Sciences;journal;18790631, 00243205;1.014;Q1;174;293;764;13495;2382;764;2.83;46.06;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
152;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.997;Q1;46;33;70;4134;211;70;3.4;125.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
153;20663;Current Drug Metabolism;journal;18755453, 13892002;0.993;Q1;111;98;277;10022;1410;259;5.15;102.27;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmacology (Q1); Clinical Biochemistry (Q2)"
154;25109;Inhalation Toxicology;journal;08958378, 10917691;0.992;Q2;90;104;402;4631;1020;390;2.02;44.53;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
155;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.991;Q2;96;136;385;5427;1002;379;2.66;39.9;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
156;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.988;Q2;103;89;172;4937;591;167;3.41;55.47;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
157;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.987;Q1;79;129;344;3576;812;341;2.23;27.72;United States;Northern America;SAGE Publications Inc.;1996-2017;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
158;144790;Marine Drugs;journal;16603397;0.983;Q1;128;171;240;9262;1110;239;4.47;54.16;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q1)
159;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.982;Q1;53;87;214;4822;486;198;2.97;55.43;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (clinical) (Q2); Molecular Medicine (Q2); Genetics (Q3)"
160;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.979;Q2;87;158;604;5620;1487;602;2.32;35.57;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
161;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.979;Q2;81;81;540;3789;1329;525;2.54;46.78;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
162;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.978;Q1;95;98;256;3654;797;246;2.79;37.29;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
163;130063;Pharmacological Reports;journal;17341140;0.977;Q2;87;154;390;6575;1145;375;2.72;42.69;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
164;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.973;Q2;51;45;135;5658;522;135;3.93;125.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
165;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.972;Q2;51;59;129;4860;479;124;3.89;82.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
166;22477;Investigational New Drugs;journal;01676997, 15730646;0.969;Q2;90;175;249;5504;685;248;2.47;31.45;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2)"
167;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.963;Q2;64;46;99;1368;233;96;2.19;29.74;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
168;19700194010;MedChemComm;journal;20402503, 20402511;0.962;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
169;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.962;Q2;36;6;28;836;61;17;1.75;139.33;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
170;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.961;Q2;40;28;85;2577;253;84;1.98;92.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Hematology (Q2); Pharmacology (Q2)"
171;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.957;Q1;104;95;245;4269;852;236;3.3;44.94;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
172;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.951;Q2;76;46;142;2478;372;140;2.88;53.87;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
173;24785;Alcohol;journal;07418329;0.95;Q2;83;73;214;3742;622;211;2.71;51.26;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
174;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.944;Q2;63;74;182;7940;574;169;3.17;107.3;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
175;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.942;Q2;90;129;279;5075;590;279;1.94;39.34;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
176;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.94;Q1;80;184;222;3538;935;217;4.56;19.23;United States;Northern America;American Scientific Publishers;2007-2020;"Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
177;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.939;Q2;104;180;476;7704;1301;454;2.58;42.8;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
178;16948;Chirality;journal;1520636X, 08990042;0.932;Q2;80;143;422;5828;1147;416;2.59;40.76;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
179;16533;Phytochemical Analysis;journal;09580344, 10991565;0.931;Q2;76;75;219;1857;592;214;2.79;24.76;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2)"
180;4700152848;PPAR Research;journal;16874757, 16874765;0.929;Q2;52;19;215;948;478;202;1.77;49.89;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
181;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.928;Q1;57;116;162;4581;350;149;2.16;39.49;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
182;14805;Steroids;journal;0039128X, 18785867;0.925;Q2;107;214;471;8929;1478;466;3.03;41.72;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
183;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.921;Q1;18;13;7;776;25;6;3.57;59.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
184;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.921;Q2;96;103;348;3197;1117;340;2.83;31.04;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
185;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.912;Q2;80;175;533;6383;1372;525;1.94;36.47;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
186;22319;Toxicon;journal;18793150, 00410101;0.908;Q2;133;212;885;9582;2476;864;2.86;45.2;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
187;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.906;Q2;39;79;94;1629;164;90;1.6;20.62;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
188;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.891;Q2;94;64;331;2607;931;322;2.8;40.73;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q2); Molecular Medicine (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3)"
189;25214;Toxicologic Pathology;journal;15331601, 01926233;0.869;Q2;112;120;339;4800;874;308;2.32;40;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
190;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.865;Q1;48;89;273;1593;387;176;1.25;17.9;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
191;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.865;Q2;112;144;437;6615;1121;397;2.71;45.94;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
192;29053;Molecular Diversity;journal;1573501X, 13811991;0.864;Q2;58;98;159;3755;475;153;2.89;38.32;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
193;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.855;Q2;95;108;395;10227;1168;393;2.82;94.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
194;14822;Xenobiotica;journal;00498254, 13665928;0.85;Q2;82;108;278;3962;730;273;1.9;36.69;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
195;22411;Inflammopharmacology;journal;09254692, 15685608;0.849;Q2;55;36;102;1754;310;99;2.47;48.72;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
196;25224;Toxicology in Vitro;journal;18793177, 08872333;0.846;Q2;112;266;723;11245;2201;716;3.07;42.27;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
197;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.845;Q2;76;166;260;10362;503;196;1.93;62.42;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
198;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.836;Q1;69;79;211;2751;511;186;2.35;34.82;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
199;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.832;Q2;90;170;487;5582;980;484;1.78;32.84;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
200;22432;International Immunopharmacology;journal;18781705, 15675769;0.828;Q2;119;316;703;14699;2030;688;2.68;46.52;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
201;4000150314;Chemical Biology and Drug Design;journal;17470277;0.824;-;82;167;399;5951;1011;388;2.44;35.63;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
202;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.82;Q2;91;91;302;4490;836;300;2.77;49.34;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
203;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.82;Q2;75;78;183;2620;446;177;2.32;33.59;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
204;22378;Vascular Pharmacology;journal;18793649, 15371891;0.816;Q2;100;42;200;2140;493;196;2.24;50.95;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Physiology (Q2); Molecular Medicine (Q3)"
205;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.811;Q2;54;17;57;690;152;54;2.45;40.59;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q2)"
206;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.805;Q2;92;127;532;5595;1107;516;2.04;44.06;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
207;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.802;Q2;93;135;442;5107;1206;436;2.26;37.83;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
208;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.8;Q2;83;259;847;18824;2390;814;2.96;72.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
209;16573;Phytotherapy Research;journal;10991573, 0951418X;0.794;Q2;140;290;919;9004;2533;918;2.57;31.05;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
210;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.793;Q2;67;120;395;1986;531;358;1.26;16.55;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
211;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.785;Q2;109;98;349;3177;961;341;2.32;32.42;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
212;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;0.785;Q1;16;2;13;81;36;13;4.5;40.5;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
213;25898;Journal of Peptide Science;journal;10752617, 10991387;0.783;Q2;68;113;370;3995;704;361;1.78;35.35;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
214;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.778;Q2;55;48;131;4761;339;115;2.67;99.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
215;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.773;Q2;52;81;246;1606;298;219;1.33;19.83;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
216;25093;Environmental Toxicology;journal;15227278, 15204081;0.769;Q2;81;74;235;3285;510;234;2.11;44.39;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
217;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.768;Q2;56;38;81;1759;188;80;2.42;46.29;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
218;20027;BMC Pharmacology;journal;14712210;0.766;Q2;44;14;56;500;149;56;2.69;35.71;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
219;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.763;Q2;80;59;233;1413;619;208;2.58;23.95;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
220;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.761;Q2;98;150;513;3480;959;415;2.05;23.2;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
221;110172;Progress in Drug Research;book series;0071786X;0.76;Q1;44;15;20;1405;61;18;0;93.67;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
222;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.759;Q2;47;32;115;2040;279;108;1.95;63.75;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
223;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.756;Q2;107;139;662;5402;1331;624;2.02;38.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
224;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.752;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
225;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.75;Q2;52;56;136;2389;336;127;2.04;42.66;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
226;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.745;Q1;36;18;59;2216;175;59;2.73;123.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
227;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.744;Q2;64;34;150;1705;431;149;3.24;50.15;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
228;130047;Current Drug Discovery Technologies;journal;15701638;0.74;Q2;44;38;95;2659;276;90;2.98;69.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
229;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.737;Q1;54;42;115;1623;195;101;1.61;38.64;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
230;23942;Biomedical Chromatography;journal;10990801, 02693879;0.735;Q2;68;164;548;5271;1109;537;2.04;32.14;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
231;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.726;Q2;64;100;259;2770;489;248;1.91;27.7;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
232;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.725;Q2;87;108;384;4457;781;376;2.03;41.27;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
233;21194;Pharmacology;journal;00317012, 14230313;0.725;Q2;60;90;285;2968;588;258;1.74;32.98;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
234;26370;Molecules;journal;14203049;0.72;Q1;171;757;1295;30780;3563;1290;2.7;40.66;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
235;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.718;Q2;32;30;75;2410;168;74;2.29;80.33;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
236;21229;Drug News and Perspectives;journal;02140934;0.711;Q2;51;0;210;0;413;205;1.83;0;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
237;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.708;Q1;61;48;151;1791;357;151;2.47;37.31;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
238;21744;Planta Medica;journal;14390221, 00320943;0.707;Q1;122;275;789;9024;1955;777;2.17;32.81;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
239;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.703;Q1;122;329;1187;11011;2607;1167;1.92;33.47;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
240;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.701;Q2;98;201;597;8776;1278;593;2;43.66;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.7;Q2;48;57;128;3887;288;115;2.19;68.19;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
242;5800173401;Current Bioactive Compounds;journal;15734072;0.696;Q1;27;30;75;1859;123;66;1.72;61.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
243;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.695;Q2;64;40;114;1096;133;100;1.08;27.4;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
244;20570;Chemotherapy;journal;00093157, 14219794;0.694;Q2;58;51;206;1741;393;201;1.7;34.14;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.694;Q1;124;189;591;7940;1459;584;2.45;42.01;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
246;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.691;Q1;63;121;288;3291;509;264;1.46;27.2;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
247;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.685;Q2;53;103;308;3032;657;301;1.8;29.44;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
248;19374;AAPS PharmSciTech;journal;15309932;0.684;Q1;101;155;541;4241;1073;541;1.85;27.36;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
249;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.673;Q2;70;96;219;3612;570;215;2.81;37.63;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
250;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.672;Q2;34;17;64;2366;149;64;2.34;139.18;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
251;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.666;Q2;99;375;1208;5303;1556;718;1.3;14.14;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
252;6400153120;Chinese Medicine;journal;17498546;0.666;Q2;45;42;83;2193;214;75;2.48;52.21;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
253;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.663;Q2;77;83;252;4020;585;243;2.01;48.43;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
254;22410;Inflammation Research;journal;1420908X, 10233830;0.661;Q2;94;137;429;5008;831;425;1.92;36.55;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
255;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.659;Q2;10;5;5;394;14;5;2.8;78.8;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Pharmacology (Q2); Biochemistry (Q3); Biophysics (Q3); Cell Biology (Q3)"
256;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.656;Q2;58;100;283;2048;255;150;0.99;20.48;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
257;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.655;Q1;33;27;66;1143;176;66;2.29;42.33;Spain;Western Europe;Elsevier Espana;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Agricultural and Biological Sciences (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
258;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.653;Q2;76;90;268;2831;526;252;1.97;31.46;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
259;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.65;Q2;63;86;261;3784;560;251;2.15;44;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
260;15840;Journal of Antibiotics;journal;00218820, 18811469;0.648;Q2;84;132;353;3602;594;344;1.66;27.29;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
261;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.645;Q2;66;93;284;4945;628;256;1.96;53.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
262;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.64;Q2;76;266;838;4885;1146;836;1.22;18.36;United States;Northern America;Springer New York;1966-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
263;19700175230;Drug Design, Development and Therapy;journal;11778881;0.64;Q1;71;38;84;3421;230;82;3.09;90.03;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
264;23039;Journal of Liposome Research;journal;08982104, 15322394;0.64;Q1;53;39;102;1408;211;100;1.82;36.1;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
265;20026;BMC Clinical Pharmacology;journal;14726904;0.639;Q2;39;23;47;722;139;47;3;31.39;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
266;16067;Reading Teacher;journal;00340561;0.639;Q2;53;89;246;1572;225;239;0.77;17.66;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
267;19600166320;Protein and Cell;journal;16748018, 1674800X;0.632;Q2;74;119;134;5192;179;126;1.34;43.63;China;Asiatic Region;Higher Education Press;2010-2021;"Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3)"
268;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.631;Q2;39;124;251;4997;576;251;2.44;40.3;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q2)
269;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.629;Q1;24;26;3;959;13;3;4.33;36.88;United States;Northern America;OMICS Publishing Group;2010-2014;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
270;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.627;Q2;85;260;790;6898;1254;789;1.63;26.53;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
271;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.621;Q2;68;92;288;8715;566;283;2.24;94.73;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q2)
272;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.616;Q2;74;57;220;2460;428;220;2.01;43.16;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
273;19700188217;Bioanalysis;journal;17576180, 17576199;0.614;Q1;62;295;304;7348;666;270;2.19;24.91;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
274;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.609;Q2;23;1;67;23;113;55;1.38;23;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
275;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.604;Q2;38;31;63;973;127;61;1.55;31.39;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
276;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.604;Q1;50;103;261;2512;517;260;1.71;24.39;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
277;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.6;Q2;88;121;346;5263;662;343;1.77;43.5;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q3)"
278;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.599;Q1;65;91;228;2621;493;227;2.08;28.8;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
279;130025;Current Drug Delivery;journal;15672018;0.599;Q1;65;68;160;4369;346;159;1.92;64.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
280;24071;Metal-Based Drugs;journal;07930291, 16875486;0.597;Q2;38;1;25;34;86;24;2.71;34;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Pharmacology (Q2); Toxicology (Q3)"
281;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.588;Q2;49;86;215;5033;441;176;2.32;58.52;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Clinical Biochemistry (Q3)"
282;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.587;Q1;81;43;125;1846;316;122;2.13;42.93;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
283;18077;Fitoterapia;journal;0367326X, 18736971;0.585;Q2;110;204;459;6301;1056;458;2.15;30.89;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
284;19300156901;Dose-Response;journal;15593258;0.584;Q3;41;41;84;1725;175;82;2.16;42.07;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
285;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.583;Q2;62;96;385;2922;382;380;0.67;30.44;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
286;4700152612;Current Nanoscience;journal;15734137;0.582;Q2;47;135;212;6698;462;212;1.93;49.61;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
287;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.582;Q2;52;47;122;2070;261;119;2.19;44.04;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
288;20770;Drug Delivery;journal;10717544, 15210464;0.58;Q2;72;80;190;3361;351;188;1.66;42.01;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
289;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.576;Q2;95;283;969;7166;1811;969;1.76;25.32;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
290;23412;Journal of AOAC International;journal;10603271;0.572;Q2;90;210;685;5595;1010;666;1.28;26.64;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
291;24578;Mathematical Medicine and Biology;journal;14778599;0.561;Q2;46;17;56;653;103;56;2.09;38.41;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
292;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.56;Q2;93;261;725;7792;1381;704;1.75;29.85;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
293;17500155003;Records of Natural Products;journal;13076167;0.554;Q2;33;44;57;1148;111;56;1.95;26.09;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2); Organic Chemistry (Q3)"
294;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.552;Q3;42;38;105;1666;232;104;2.25;43.84;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
295;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.546;Q2;31;24;74;512;99;64;0.8;21.33;United States;Northern America;Springer New York;2006-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
296;25864;Heterocycles;journal;03855414;0.544;Q2;66;228;1079;8242;1272;1072;1.16;36.15;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
297;13671;Biologicals;journal;10958320, 10451056;0.543;Q2;60;72;240;1950;471;228;1.96;27.08;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
298;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.543;Q1;36;27;42;1056;87;41;0.96;39.11;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
299;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.54;Q1;59;8;265;353;623;264;2.66;44.13;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
300;20634;Journal of Texture Studies;journal;00224901, 17454603;0.539;Q2;57;49;133;1847;150;133;0.93;37.69;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
301;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.538;Q3;40;43;120;2180;212;119;1.35;50.7;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
302;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.538;Q2;81;83;220;3085;423;220;1.88;37.17;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Colloid and Surface Chemistry (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
303;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.533;Q2;50;40;129;1795;268;128;2.02;44.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
304;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.531;Q2;31;32;74;2728;157;70;1.89;85.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
305;5800173386;Current Drug Safety;journal;15748863;0.526;Q2;37;57;117;2359;248;107;2.05;41.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
306;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.526;Q3;40;30;97;1699;165;93;1.7;56.63;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
307;10900153302;Biomarker Insights;journal;11772719;0.525;Q2;35;17;62;571;119;62;2.74;33.59;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
308;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.516;Q3;62;48;143;1818;238;140;1.48;37.88;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
309;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.504;Q2;27;15;78;807;105;70;1.15;53.8;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q2); Molecular Medicine (Q3)"
310;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.504;Q2;19;17;65;72;49;55;0.84;4.24;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q1); Pharmacy (Q1); Pharmacology (Q2)"
311;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;0.502;Q1;31;26;88;1102;77;87;0.88;42.38;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
312;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.502;Q2;65;35;110;1068;277;108;2.01;30.51;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
313;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.497;Q2;42;18;97;1059;155;93;1.22;58.83;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Hematology (Q3); Molecular Medicine (Q3)"
314;19900192900;Molecular Informatics;journal;18681751, 18681743;0.496;Q3;70;87;285;3751;643;277;1.92;43.11;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
315;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.487;Q2;58;226;449;5255;955;429;2.4;23.25;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
316;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.487;Q2;79;110;431;4132;730;429;1.63;37.56;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
317;25171;Mycotoxin Research;journal;18671632, 01787888;0.487;Q3;40;34;89;1232;132;83;1.65;36.24;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
318;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.485;Q2;62;71;210;2233;283;206;1.37;31.45;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
319;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.484;Q2;42;58;228;1647;331;219;1.58;28.4;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
320;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.477;Q2;21;8;54;261;66;54;1.17;32.63;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q2)
321;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.474;Q2;66;77;133;2762;232;128;1.4;35.87;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
322;21264;Drugs in R and D;journal;11796901, 11745886;0.473;Q2;47;30;71;1169;137;69;1.14;38.97;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q2)
323;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.462;Q3;52;83;361;2492;407;317;1.09;30.02;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
324;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.461;Q3;53;98;258;3896;390;257;1.55;39.76;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
325;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.459;Q3;66;27;119;1277;167;118;1.39;47.3;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Biology (Q4)"
326;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.459;Q3;52;70;208;1209;287;175;1.2;17.27;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
327;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.458;Q2;42;91;232;2336;436;231;1.87;25.67;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
328;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.457;Q2;51;194;572;5233;514;567;0.77;26.97;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
329;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.457;Q3;56;27;84;2375;149;76;1.98;87.96;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
330;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.456;Q3;29;23;83;2464;166;83;2.09;107.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
331;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.455;Q3;63;122;326;4307;463;304;1.32;35.3;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
332;19700175819;Patient Preference and Adherence;journal;1177889X;0.454;Q1;54;71;120;2594;186;119;1.67;36.54;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Social Sciences (miscellaneous) (Q2)"
333;26767;Altex;journal;1868596X, 18688551;0.453;Q3;57;36;93;1420;212;81;2.75;39.44;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
334;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.451;Q3;50;426;1087;10656;1302;1070;1.37;25.01;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
335;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.447;Q3;61;70;286;1225;343;225;1.02;17.5;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
336;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.445;Q3;50;136;221;4363;223;215;0.98;32.08;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
337;15340;Developments in Biologicals;journal;14246074, 16622960;0.444;Q3;38;0;123;0;149;121;0;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Biomaterials (Q3); Immunology (Q3); Pharmacology (Q3)"
338;19400158813;HIV Therapy;journal;17584329, 17584310;0.444;Q3;12;0;108;0;68;79;0.63;0;United Kingdom;Western Europe;Future Medicine Ltd.;2009-2010;"Dermatology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Virology (Q3)"
339;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.443;Q2;61;129;502;2843;810;502;1.18;22.04;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
340;25106;Human and Experimental Toxicology;journal;09603271;0.433;Q3;82;229;355;8489;567;320;1.53;37.07;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
341;27210;In Vivo;journal;17917549, 0258851X;0.432;Q3;64;136;444;4068;611;442;1.37;29.91;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
342;17700156714;Pharmaceuticals;journal;14248247;0.431;Q2;69;89;208;7520;256;204;1.23;84.49;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q2); Molecular Medicine (Q3)"
343;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.426;Q3;69;119;367;2600;504;345;1.16;21.85;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
344;130089;Toxin Reviews;journal;15569543, 15569551;0.426;Q3;46;13;62;800;90;60;1.42;61.54;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
345;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.422;Q3;53;73;295;4139;466;290;1.65;56.7;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
346;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.422;Q3;21;7;22;278;41;22;1.43;39.71;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
347;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.417;Q2;25;37;86;1517;111;85;1.29;41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
348;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.415;Q3;62;76;191;3019;284;183;1.45;39.72;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
349;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.415;Q3;62;113;215;4028;339;209;1.57;35.65;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
350;18800156720;Dissolution Technologies;journal;1521298X;0.414;Q2;34;29;72;574;66;70;0.7;19.79;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
351;21207;Drug Discovery Today: Technologies;journal;17406749;0.414;Q3;53;18;64;601;89;56;1.15;33.39;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
352;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.412;Q1;69;233;541;3476;696;464;1.07;14.92;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
353;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.411;Q2;60;40;120;782;267;120;1.69;19.55;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
354;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.405;Q2;39;100;145;2148;238;139;1.64;21.48;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
355;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.403;Q3;47;31;97;1364;130;97;1.22;44;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
356;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.396;Q2;42;170;533;2915;562;532;1.09;17.15;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
357;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.395;Q2;28;37;123;1126;151;121;1.05;30.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
358;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.395;Q3;32;45;86;1305;83;85;0.8;29;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
359;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.393;Q3;26;23;58;469;80;58;1.38;20.39;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
360;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.391;Q1;21;17;72;377;98;72;1.35;22.18;United States;Northern America;Science Publications;2007-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
361;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.391;Q1;91;173;526;6211;787;521;1.34;35.9;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Cell Biology (Q4); Physiology (Q4)"
362;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.389;Q3;28;26;79;2513;104;79;1.24;96.65;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Pharmacology (medical) (Q2); Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3)"
363;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.387;Q1;61;127;394;4142;649;389;1.44;32.61;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
364;19700175061;Open Pharmacology Journal;journal;18741436;0.384;Q2;6;1;9;28;6;9;0.67;28;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
365;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.383;Q2;39;62;293;1558;159;270;0.7;25.13;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
366;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.381;Q3;38;39;119;1204;136;118;1.18;30.87;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
367;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.381;Q2;46;64;156;1844;215;152;1.31;28.81;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
368;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.381;Q3;46;80;248;4028;296;242;1.23;50.35;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
369;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.379;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
370;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.375;Q3;29;23;71;651;62;60;0.68;28.3;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
371;25144;Journal of Health Science;journal;13475207, 13449702;0.373;Q3;49;70;329;2457;381;327;1.03;35.1;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
372;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.371;Q3;46;63;147;2035;195;147;1.28;32.3;United States;Northern America;Informa Healthcare;1977-2021;"Medicine (miscellaneous) (Q2); Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
373;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.37;Q1;48;112;154;3081;156;142;0.85;27.51;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q3)"
374;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.37;Q3;33;58;190;2134;196;190;1.09;36.79;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q3); Physiology (Q4)"
375;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.37;Q3;46;80;194;3647;281;194;1.5;45.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
376;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.367;Q3;48;34;138;791;126;131;0.81;23.26;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
377;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.367;Q3;41;0;36;0;43;15;0;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
378;21192;Drug Development Research;journal;02724391, 10982299;0.366;Q3;62;83;168;5296;194;161;1.29;63.81;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
379;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.365;Q2;49;573;387;13596;490;386;1.27;23.73;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
380;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.364;Q3;24;0;68;0;71;65;0.77;0;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
381;144963;Drug Discovery Today: Disease Models;journal;17406757;0.364;Q3;28;24;79;1114;72;68;0.61;46.42;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
382;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.364;Q2;72;178;537;6266;647;531;1.1;35.2;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
383;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.363;Q2;63;930;564;28043;903;558;1.6;30.15;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
384;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.359;Q3;51;123;545;4341;458;519;0.82;35.29;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
385;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;0.355;Q3;54;23;70;1716;105;70;1.5;74.61;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
386;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.353;Q3;53;59;169;1229;173;142;0.88;20.83;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
387;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.35;Q3;36;29;79;893;62;79;0.75;30.79;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
388;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.347;Q2;29;11;9;472;10;8;1.11;42.91;United States;Northern America;Springer Science + Business Media;2010-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
389;4500151530;Personalized Medicine;journal;17410541;0.337;Q3;33;79;240;2697;250;185;1.19;34.14;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
390;19700188352;Toxins;journal;20726651;0.337;Q3;91;91;168;6200;186;167;1.11;68.13;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
391;21717;Die Pharmazie;journal;00317144;0.335;Q2;66;175;511;4648;584;510;1.16;26.56;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
392;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.332;Q2;52;60;176;3711;152;174;0.81;61.85;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
393;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.331;Q3;37;45;158;1658;187;155;1.14;36.84;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
394;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.331;Q3;3;0;2;0;4;2;2;0;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q3); Food Science (Q3); Toxicology (Q3)"
395;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.33;Q1;23;37;108;846;117;99;1.08;22.86;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
396;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.329;Q3;48;90;123;2966;187;122;1.48;32.96;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
397;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.325;Q3;48;119;335;3002;271;332;0.79;25.23;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3); Biochemistry (Q4)"
398;110097;Food and Drug Law Journal;journal;1064590X;0.322;Q3;22;25;110;4417;63;109;0.55;176.68;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
399;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.322;Q2;26;19;61;957;72;50;1.18;50.37;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
400;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.321;Q2;57;59;135;1509;121;132;1;25.58;United States;Northern America;Informa Healthcare;2013-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
401;19700174961;BioProcess International;trade journal;15426319;0.321;Q3;23;183;291;883;162;286;0.56;4.83;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
402;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.32;Q2;16;13;16;349;14;13;0.88;26.85;United States;Northern America;IPEC-Americas;2010-2021;"Pharmaceutical Science (Q2); Food Science (Q3)"
403;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.319;Q2;26;62;123;1707;139;117;1.13;27.53;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
404;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.318;Q1;48;117;468;3113;397;466;0.81;26.61;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
405;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.318;Q3;33;63;130;1968;128;129;0.95;31.24;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
406;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.315;Q2;40;84;170;1419;135;156;0.68;16.89;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
407;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.314;Q2;50;213;228;5609;280;228;1.19;26.33;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
408;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.313;Q2;15;54;56;1250;14;42;0.25;23.15;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Decision Sciences (miscellaneous) (Q3)"
409;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.312;Q3;32;70;117;1462;127;114;1.11;20.89;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
410;19446;American Pharmaceutical Review;journal;10998012;0.31;Q2;24;78;271;1183;137;270;0.61;15.17;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q2)
411;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.309;Q3;30;72;216;3634;122;210;0.51;50.47;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
412;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.309;Q3;62;200;280;3506;317;217;0.94;17.53;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;20578;Journal of Food and Drug Analysis;journal;10219498;0.304;Q3;63;64;188;2296;170;188;0.85;35.88;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
414;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.302;Q2;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
415;19700174969;Archives of Drug Information;journal;17535174;0.301;Q2;11;4;31;73;33;30;1.47;18.25;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
416;35190;Revista Espanola de Quimioterapia;journal;02143429;0.301;Q3;26;44;125;994;85;105;0.69;22.59;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
417;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.298;Q3;24;93;220;1692;117;47;0.46;18.19;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
418;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.298;Q3;35;0;502;0;360;502;0.81;0;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
419;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.297;Q2;46;69;197;5043;142;167;0.76;73.09;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
420;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.296;Q2;33;408;228;11628;265;228;1.16;28.5;Nigeria;Africa;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
421;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.295;Q3;29;91;186;2707;95;186;0.48;29.75;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
422;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.293;Q3;47;57;159;1338;167;158;0.86;23.47;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
423;23171;Korean Journal of Pharmacognosy;journal;02533073;0.293;Q2;17;46;182;1104;92;182;0.43;24;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
424;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.293;Q2;50;203;430;7077;405;419;0.62;34.86;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
425;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.292;Q2;8;11;14;615;14;14;1;55.91;Switzerland;Western Europe;Inderscience Publishers;2011;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
426;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.291;Q3;19;30;85;2789;112;75;1.61;92.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
427;19700175149;African Journal Biomedical Research;journal;11195096;0.287;Q2;17;36;83;854;54;83;0.33;23.72;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
428;130038;Letters in Drug Design and Discovery;journal;15701808;0.285;Q2;35;133;298;3677;273;298;0.94;27.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
429;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.285;Q3;53;0;224;0;209;214;0.85;0;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
430;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.284;Q3;20;68;59;1796;51;59;0.86;26.41;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
431;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.283;Q2;18;58;99;2084;99;99;1.26;35.93;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
432;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.282;Q2;28;36;104;968;65;102;0.47;26.89;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
433;59665;Chinese Journal of Natural Medicines;journal;16723651;0.281;Q3;40;87;228;2035;186;225;1;23.39;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
434;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.275;Q2;25;17;57;567;36;55;0.66;33.35;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
435;19700178100;Nanotechnology, Science and Applications;journal;11778903;0.274;Q2;30;10;17;1114;24;17;1.41;111.4;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Bioengineering (Q4); Nanoscience and Nanotechnology (Q4)"
436;19700188360;Pharmaceutics;journal;19994923;0.274;Q2;68;49;30;3202;24;29;0.8;65.35;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q2)
437;73430;Pharmaceutical Technology;journal;15432521;0.271;Q2;38;247;566;967;128;453;0.25;3.91;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q4)"
438;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.27;Q2;38;18;11;1092;22;11;2;60.67;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Molecular Medicine (Q4)"
439;19700175040;Open Vaccine Journal;journal;18750354;0.27;Q2;9;4;37;262;16;36;0.43;65.5;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Immunology (Q4)"
440;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.269;Q2;23;16;34;376;34;33;0.77;23.5;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
441;21100205919;Open Drug Discovery Journal;journal;18773818;0.268;Q3;9;0;26;0;11;23;0.42;0;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery (Q3)
442;22881;Yaoxue Xuebao;journal;05134870;0.267;Q2;34;248;720;5261;440;719;0.59;21.21;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
443;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.265;Q2;21;97;73;2188;84;73;1.15;22.56;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
444;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.265;Q3;18;39;54;1631;46;54;0.85;41.82;United States;Northern America;Academic Journals Inc.;2009-2016;"Pollution (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
445;21810;Farmacia;journal;00148237;0.264;Q2;27;89;259;1509;176;259;0.76;16.96;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
446;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.263;Q2;38;26;60;697;31;54;0.52;26.81;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q2)
447;21100470510;Drug Research;journal;21949379, 21949387;0.262;Q3;65;124;369;2834;274;363;0.77;22.85;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
448;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.26;Q3;48;49;86;7199;57;78;0.6;146.92;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q3); Cancer Research (Q4)"
449;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.259;Q2;45;129;324;3078;312;323;0.98;23.86;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
450;23489;Chemical Speciation and Bioavailability;journal;09542299;0.259;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
451;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.255;Q3;34;16;64;376;24;57;0.31;23.5;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
452;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.254;Q2;41;210;143;4928;128;141;0.9;23.47;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
453;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.253;Q3;16;38;25;1422;26;25;1.04;37.42;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Pharmacology (Q3); Biochemistry (Q4)"
454;19200156925;Cancer Therapy;journal;15439143, 15439135;0.252;Q3;8;3;65;159;35;65;0.54;53;United States;Northern America;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
455;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.252;Q3;37;49;79;1225;74;75;0.94;25;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q3); Pharmacology (Q3)"
456;22205;Saudi Pharmaceutical Journal;journal;13190164;0.252;Q2;57;35;102;1188;102;100;1.14;33.94;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
457;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.251;Q3;22;66;176;2134;117;155;0.71;32.33;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
458;21496;Revista de Chimie (discontinued);journal;00347752;0.251;-;31;240;826;5048;427;824;0.6;21.03;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
459;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.25;Q3;29;43;63;871;43;45;0.68;20.26;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
460;24097;Journal of the Indian Chemical Society;journal;00194522;0.247;Q3;33;242;678;7506;314;665;0.46;31.02;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q3); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
461;130031;Journal of Toxicologic Pathology;journal;09149198;0.246;Q4;30;34;107;957;50;107;0.49;28.15;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
462;20065;BioPharm International;trade journal;1542166X, 19391862;0.244;Q2;29;116;318;624;127;284;0.36;5.38;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
463;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.24;Q3;10;0;15;0;4;13;0;0;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q4)"
464;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.239;Q3;48;322;664;6492;526;664;0.79;20.16;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
465;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.237;Q3;25;7;49;314;63;47;1.84;44.86;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
466;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.237;Q3;30;109;191;2717;166;191;0.87;24.93;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
467;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.235;Q3;29;35;103;1097;67;103;0.45;31.34;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
468;20564;Ceska a Slovenska Farmacie;journal;12107816;0.233;Q3;17;41;115;1208;30;112;0.26;29.46;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
469;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.233;Q4;7;0;44;0;13;42;0.3;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
470;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;0.232;Q3;15;30;16;1108;11;15;0.69;36.93;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Biomedical Engineering (Q3); Pharmaceutical Science (Q3); Nanoscience and Nanotechnology (Q4)"
471;19500156813;Procedia in Vaccinology;journal;1877282X;0.228;Q3;15;43;67;1342;36;65;0.54;31.21;Netherlands;Western Europe;Elsevier;2009-2012;"Infectious Diseases (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
472;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.226;Q3;26;40;55;2644;35;50;0.64;66.1;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
473;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.226;Q3;13;23;82;370;34;82;0.14;16.09;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
474;21265;Drugs of the Future;journal;03778282;0.221;Q3;45;104;343;6120;197;342;0.59;58.85;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
475;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.22;Q3;39;43;79;1135;53;78;0.49;26.4;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
476;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.22;Q3;43;240;641;5521;364;595;0.45;23;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
477;15842;Journal of Applied Research;journal;1537064X;0.219;Q3;22;11;61;348;31;57;0.27;31.64;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
478;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.218;Q2;23;50;50;1451;50;50;1;29.02;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
479;79053;Natural Product Sciences;journal;12263907;0.218;Q4;28;64;148;1449;54;148;0.25;22.64;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
480;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.216;Q4;7;5;8;94;6;8;0.75;18.8;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
481;22908;Chinese Pharmacological Bulletin;journal;10011978;0.215;Q3;17;439;1282;6536;677;1282;0.58;14.89;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
482;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.214;Q4;14;27;80;588;35;78;0.48;21.78;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q4); Drug Discovery (Q4)"
483;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.212;Q2;30;56;83;1019;64;76;0.77;18.2;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
484;21758;Prescrire International;journal;11677422;0.209;Q3;13;206;636;1493;133;528;0.24;7.25;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
485;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.208;Q4;28;16;68;522;26;50;0.52;32.63;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
486;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.207;Q2;22;58;179;1620;97;172;0.56;27.93;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
487;21102;Pharmaceutical Journal;journal;00316873;0.207;Q3;28;655;3007;461;63;855;0.02;0.7;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
488;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.207;Q4;17;36;69;1190;30;69;0.43;33.06;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
489;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.206;Q3;52;143;70;8885;53;69;0.76;62.13;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q3)
490;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.205;Q3;28;17;25;1010;18;25;0.72;59.41;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q3)
491;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.198;Q3;44;71;186;3071;118;186;0.72;43.25;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
492;5800173394;Current Drug Therapy;journal;15748855;0.197;Q2;17;33;84;2889;58;81;0.59;87.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
493;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.197;Q3;13;0;72;0;32;70;0.29;0;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
494;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.197;Q3;14;42;90;944;19;81;0.15;22.48;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
495;15600154705;EnvironmentAsia;journal;19061714;0.195;Q4;19;19;77;438;31;77;0.4;23.05;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
496;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.195;Q2;19;40;128;852;30;111;0.18;21.3;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
497;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.195;Q3;19;230;645;1818;54;627;0.09;7.9;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
498;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.192;Q3;10;26;33;595;17;33;0.52;22.88;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q3)
499;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.191;Q3;15;7;24;718;14;20;0.44;102.57;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
500;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.191;Q2;43;95;273;2964;144;263;0.4;31.2;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
501;19408;Actualites Pharmaceutiques;journal;05153700;0.19;Q3;5;184;496;524;13;459;0.03;2.85;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
502;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.189;Q3;11;136;451;891;16;421;0.04;6.55;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (nursing) (Q3)"
503;58808;Pharmaceutical Care and Research;journal;16712838;0.189;Q3;8;158;486;1268;34;480;0.07;8.03;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
504;5200152604;Pharma Times;journal;00316849;0.189;Q2;12;55;248;254;33;185;0.11;4.62;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
505;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.189;Q3;9;58;153;1131;19;144;0.14;19.5;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
506;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.188;Q3;48;30;68;903;37;68;0.54;30.1;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
507;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.188;Q3;4;49;160;815;10;146;0.07;16.63;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
508;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.188;Q3;33;368;306;10323;196;304;0.64;28.05;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q3)
509;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.187;Q4;12;15;81;453;24;81;0.32;30.2;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
510;17700156303;Neuromethods;book series;19406045, 08932336;0.185;Q2;21;300;140;19806;63;127;0.45;66.02;United States;Northern America;Humana Press;2009-2022;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
511;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.184;Q3;14;52;99;1430;44;99;0.44;27.5;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
512;22934;Chinese Pharmaceutical Journal;journal;10012494;0.183;Q3;21;456;1541;5830;250;1540;0.15;12.79;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
513;4700152607;Current Enzyme Inhibition;journal;15734080;0.183;Q4;18;25;63;2002;28;61;0.49;80.08;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
514;22375;Indian Drugs;journal;0019462X;0.183;Q3;31;94;434;1711;104;433;0.18;18.2;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
515;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.182;Q4;32;66;204;2259;103;181;0.49;34.23;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Infectious Diseases (Q3); Animal Science and Zoology (Q4); Parasitology (Q4); Toxicology (Q4)"
516;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.18;Q3;12;17;26;511;18;26;0.69;30.06;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
517;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.179;Q3;24;36;111;3401;43;101;0.52;94.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
518;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.176;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
519;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.176;Q3;5;0;5;0;2;5;0.4;0;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
520;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.174;Q3;15;31;122;314;55;109;0.35;10.13;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
521;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.174;Q3;13;61;207;426;27;140;0.13;6.98;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
522;73076;Drug Discovery World;journal;14694344;0.172;Q4;13;38;136;609;34;122;0.22;16.03;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
523;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.172;Q2;12;12;22;266;19;22;0.86;22.17;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
524;19700175096;Pharmacognosy Journal;journal;09753575;0.171;Q3;25;137;179;3552;89;177;0.5;25.93;India;Asiatic Region;EManuscript Technologies;2009-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
525;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.17;Q4;12;85;118;1073;16;117;0.05;12.62;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
526;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.17;Q3;16;25;68;649;18;68;0.24;25.96;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
527;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.169;Q3;13;33;93;898;17;89;0.12;27.21;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
528;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.168;Q3;50;15;36;640;27;35;0.75;42.67;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q3); Pharmacology (Q3)"
529;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.167;Q3;3;16;67;315;4;63;0.1;19.69;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
530;21100214102;Frontiers in Pharmacology;journal;16639812;0.166;Q3;104;88;41;5841;32;41;0.78;66.38;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
531;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.166;Q2;17;30;78;1038;35;66;0.48;34.6;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
532;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.165;Q3;42;27;117;689;66;115;0.44;25.52;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
533;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.165;Q3;25;16;35;598;21;33;0.6;37.38;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Pharmacology (Q3); Health Policy (Q4)"
534;19700170617;EXCLI Journal;journal;16112156;0.165;Q3;43;44;48;1448;56;47;1.17;32.91;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Pharmacology (Q3); Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
535;80593;Journal of Medicinal Plants;journal;16840240;0.165;Q3;23;78;240;2323;83;240;0.27;29.78;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
536;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.164;Q3;11;82;184;673;38;152;0.21;8.21;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
537;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.164;Q3;34;32;79;1322;44;75;0.62;41.31;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
538;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.164;Q3;27;383;925;9155;296;924;0.24;23.9;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
539;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.164;Q3;24;145;425;2760;148;425;0.26;19.03;India;Asiatic Region;Rasayan Journal;2008-2021;"Chemical Engineering (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Chemistry (miscellaneous) (Q4)"
540;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.163;Q4;27;261;696;5447;115;696;0.17;20.87;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
541;19700177006;Psychopharm Review;trade journal;19369255;0.163;Q3;4;12;24;518;9;24;0.38;43.17;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q4)"
542;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.162;Q3;17;16;45;249;16;43;0.41;15.56;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
543;19700188318;International Journal of Advances in Pharmaceutical Sciences (discontinued);journal;09761055;0.162;Q3;11;6;51;177;31;51;0.61;29.5;United States;Northern America;Advanced Research Journals;2010-2011;"Pharmaceutical Science (Q3); Physical and Theoretical Chemistry (Q4)"
544;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.161;Q3;27;46;147;1402;67;129;0.55;30.48;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
545;19700174889;Drug Target Insights;journal;11773928;0.161;Q3;13;2;15;83;2;15;0;41.5;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Clinical Biochemistry (Q4)"
546;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.161;Q3;3;4;9;81;3;8;0.33;20.25;New Zealand;Pacific Region;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
547;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.16;Q4;16;14;79;1436;40;74;0.46;102.57;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
548;21142;Pharmaceutisch Weekblad;journal;00316911;0.16;Q4;9;412;1205;674;20;839;0.02;1.64;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
549;5200152843;Farmaceutico Hospitales;journal;02144697;0.159;Q3;3;11;55;58;3;40;0.04;5.27;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
550;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.159;Q4;9;22;61;438;29;59;0.48;19.91;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
551;22977;Journal de Pharmacie de Belgique;journal;00472166;0.159;Q3;12;26;83;269;14;79;0.18;10.35;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
552;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.158;Q3;20;37;103;815;57;103;0.55;22.03;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
553;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.158;Q3;32;748;2072;9932;603;2072;0.26;13.28;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
554;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.157;Q4;21;10;66;342;32;66;0.17;34.2;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
555;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.156;Q4;10;17;40;849;24;36;0.82;49.94;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q3); Infectious Diseases (Q4); Pharmacology (Q4); Virology (Q4)"
556;19700170837;Vitae;journal;21452660, 01214004;0.156;Q3;15;36;67;1118;25;63;0.37;31.06;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
557;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.155;Q4;16;66;309;960;44;309;0.05;14.55;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
558;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.154;Q3;16;35;29;895;6;25;0.21;25.57;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
559;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.154;Q4;37;93;15;1210;8;10;0.53;13.01;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
560;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.154;Q3;6;37;126;291;19;119;0.16;7.86;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Pharmaceutical Science (Q3); Health Policy (Q4)"
561;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.154;Q3;10;28;119;489;24;113;0.15;17.46;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
562;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.153;Q3;21;18;15;436;9;10;0.6;24.22;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
563;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.153;Q4;39;47;9;3138;6;9;0.67;66.77;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q4); Toxicology (Q4)"
564;19700201201;EPMA Journal;journal;18785077, 18785085;0.152;Q4;39;50;57;2820;48;52;0.84;56.4;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Health Policy (Q4)"
565;13718;Pharmaceutical Engineering;journal;02738139;0.152;Q3;16;61;136;290;21;123;0.19;4.75;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
566;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.151;Q3;18;54;114;1677;27;113;0.17;31.06;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
567;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.149;Q4;20;173;292;496;64;256;0.24;2.87;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
568;19700175125;Internet Journal of Pharmacology;journal;15312976;0.148;Q4;8;6;65;108;24;65;0.37;18;United States;Northern America;Internet Scientific Publications, LLC;2009-2011;Pharmacology (Q4)
569;22906;Journal of China Pharmaceutical University;journal;10005048;0.147;Q3;14;109;349;1747;65;348;0.17;16.03;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
570;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.147;Q4;34;168;459;2688;135;457;0.27;16;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
571;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.147;Q4;31;11;20;1128;9;20;0.45;102.55;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
572;19700200880;Botulinum Journal;journal;17547326, 17547318;0.146;Q3;6;7;16;186;3;14;0.19;26.57;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
573;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.146;Q3;10;14;25;428;18;25;1.07;30.57;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
574;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.145;Q4;18;141;460;2721;45;460;0.08;19.3;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
575;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.145;Q4;5;7;13;211;4;12;0.31;30.14;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology (medical) (Q3); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
576;144879;Toxicology International;journal;09716580;0.145;Q4;28;37;63;750;35;63;0.58;20.27;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
577;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.144;Q3;7;11;37;415;12;37;0.2;37.73;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
578;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.143;Q4;22;19;17;798;15;17;0.88;42;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q4)
579;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.143;Q3;31;471;296;9512;95;296;0.32;20.2;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
580;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.142;Q3;9;9;48;175;19;44;0.4;19.44;India;Asiatic Region;;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
581;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.141;Q3;7;37;95;812;5;89;0.07;21.95;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
582;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.141;Q3;6;46;40;219;10;38;0.25;4.76;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q3)
583;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.14;Q4;44;73;77;2451;46;77;0.48;33.58;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry (Q4); Biophysics (Q4); Clinical Biochemistry (Q4); Drug Discovery (Q4); Immunology and Microbiology (miscellaneous)  (Q4)"
584;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.14;Q3;17;50;135;954;36;128;0.27;19.08;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q3)
585;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.14;Q4;25;25;75;2156;23;75;0.28;86.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Biochemistry (medical) (Q4); Drug Discovery (Q4); Immunology and Allergy (Q4)"
586;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.139;Q3;20;22;249;432;42;248;0.15;19.64;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
587;145693;Canadian Pharmacists Journal;journal;17151635;0.139;Q3;24;109;275;1008;26;152;0.1;9.25;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
588;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.139;Q4;14;16;52;1;9;52;0.17;0.06;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
589;19200156912;EJHP Practice;trade journal;20303769, 17819989;0.138;Q3;6;92;221;722;29;170;0.14;7.85;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
590;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.138;Q4;9;18;96;370;7;96;0;20.56;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
591;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.138;Q4;22;25;93;752;26;93;0.15;30.08;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
592;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.137;Q3;27;49;52;1770;17;52;0.33;36.12;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
593;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.137;Q3;35;175;489;2427;65;337;0.12;13.87;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
594;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.137;Q3;7;0;24;0;3;19;0;0;United States;Northern America;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
595;19700174940;SA Pharmaceutical Journal;journal;10151362;0.137;Q3;7;174;300;824;17;201;0.06;4.74;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q3)
596;21100197929;Toxicological Research;journal;19768257, 22342753;0.136;Q4;35;40;87;1038;13;87;0.16;25.95;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
597;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.135;Q3;24;163;121;4182;40;121;0.33;25.66;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
598;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.135;Q4;6;0;11;0;2;11;0.18;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
599;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.135;Q4;19;20;113;783;38;71;0.3;39.15;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
600;130170;Phytotherapie;journal;17652847, 16248597;0.135;Q4;18;65;196;1643;32;155;0.16;25.28;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
601;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.135;Q3;33;12;26;277;10;26;0.38;23.08;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
602;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0.134;Q3;5;0;15;0;5;15;0.33;0;Ethiopia;Africa;Ethiopian Pharmaceutical Journal;2009;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
603;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.134;Q3;9;0;18;0;8;17;0.44;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
604;11200153304;Future HIV Therapy;journal;17469600, 17469619;0.134;Q4;8;0;57;0;32;46;0;0;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2009;"Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
605;22514;Japanese Journal of Chemotherapy;journal;13407007;0.134;Q4;12;40;127;705;34;127;0.14;17.63;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
606;19700201404;Open Drug Safety Journal;journal;18768180;0.134;Q3;3;9;1;289;1;1;1;32.11;Netherlands;Western Europe;;;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
607;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.133;Q3;17;576;930;8648;135;930;0.12;15.01;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
608;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.133;Q4;10;99;216;2107;16;216;0.07;21.28;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
609;22338;Hospital Pharmacy;journal;19451253, 00185787;0.133;Q4;24;151;460;2082;68;381;0.14;13.79;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (Q4); Pharmacology (medical) (Q4)"
610;25253;Blutalkohol (discontinued);journal;00065250;0.132;Q4;13;43;107;515;6;99;0.07;11.98;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
611;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.132;Q4;12;12;12;298;9;12;0.75;24.83;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
612;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.131;Q3;24;60;51;1442;31;47;0.61;24.03;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
613;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.131;-;31;60;160;1210;46;152;0.33;20.17;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
614;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.13;Q4;11;0;79;0;27;79;0.34;0;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
615;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.13;Q4;10;0;28;0;2;11;0.07;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q4)
616;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.129;Q3;18;23;24;628;12;24;0.5;27.3;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
617;19700174658;Regulatory Rapporteur;trade journal;17428955;0.129;Q3;6;59;76;375;5;55;0.07;6.36;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacy (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
618;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.128;Q4;10;28;69;744;12;69;0.15;26.57;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
619;19700175039;Open Toxicology Journal;journal;18743404;0.128;Q4;8;0;15;0;6;15;0.4;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
620;9800153137;Trastornos Adictivos;journal;15750973;0.128;Q4;9;26;87;705;18;64;0.15;27.12;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
621;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.127;Q4;15;119;308;2141;45;305;0.12;17.99;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
622;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.127;Q4;6;15;19;170;3;17;0.16;11.33;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
623;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.127;Q4;9;31;74;522;11;60;0.2;16.84;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
624;21127;Pharmaceutical Technology Europe;journal;01646826;0.127;Q4;18;119;375;382;39;311;0.11;3.21;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
625;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;-;0.127;-;13;0;387;0;82;386;0.21;0;Belgium;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
626;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.126;Q4;14;33;93;3010;24;85;0.22;91.21;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
627;19700175105;Open Drug Delivery Journal;journal;18741266;0.126;Q4;5;0;11;0;4;10;0.36;0;Netherlands;Western Europe;;;Pharmaceutical Science (Q4)
628;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.125;Q4;11;17;23;603;6;23;0.26;35.47;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q4)
629;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.125;Q4;9;32;92;995;4;70;0.02;31.09;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
630;19700175002;Pharmaceutical Reviews;journal;19185561;0.124;Q4;5;6;51;192;16;51;0.31;32;Canada;Northern America;;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
631;21211;Pharmacy Education;journal;14772701, 15602214;0.124;Q4;18;39;39;705;4;39;0.1;18.08;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
632;19700181241;Physiology and Pharmacology;journal;17350581;0.124;Q4;12;57;89;1708;16;89;0.18;29.96;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
633;19700175015;Infection and Drug Resistance;journal;11786973;0.123;Q4;44;24;9;1292;2;8;0.22;53.83;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
634;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.122;Q4;8;15;69;357;9;69;0.09;23.8;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
635;21100469670;Antibiotics;journal;20796382;0.121;Q4;47;0;1;0;0;1;0;0;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Biochemistry (Q4); Infectious Diseases (Q4); Microbiology (Q4); Microbiology (medical) (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
636;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.121;Q4;5;110;393;1780;17;389;0.04;16.18;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
637;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.121;Q4;102;0;1;0;0;1;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q4); Food Science (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
638;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.121;Q4;11;44;87;1073;16;84;0.17;24.39;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
639;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.121;Q4;15;0;1;0;0;1;0;0;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
640;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.121;Q4;29;0;1;0;0;1;0;0;United States;Northern America;The Haworth Herbal Press;2001-2008;"Biochemistry (Q4); Pharmacology (Q4)"
641;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.12;Q4;23;47;52;936;14;45;0.27;19.91;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
642;9100153105;Current Topics in Pharmacology;journal;09724559;0.12;Q4;6;13;42;1102;9;42;0.23;84.77;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
643;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.12;Q4;10;43;39;996;14;39;0.36;23.16;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
644;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;-;0.119;-;5;0;29;0;8;28;0;0;United States;Northern America;;;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
645;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.119;Q4;5;41;84;980;9;74;0.11;23.9;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
646;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.119;Q4;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
647;19700175034;Pharmaceutical Processing;trade journal;10499156;0.119;Q4;3;44;108;44;8;87;0.07;1;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
648;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.119;Q4;13;77;251;1018;52;230;0.21;13.22;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
649;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.119;Q4;24;23;71;449;15;71;0.1;19.52;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
650;19700174886;Arzneimitteltherapie;journal;07236913;0.118;Q4;6;141;438;1075;15;201;0.03;7.62;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
651;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.118;Q4;21;11;18;591;7;0;0.4;53.73;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
652;22358;U.S. Pharmacist;trade journal;01484818;0.118;Q4;9;168;428;2749;31;397;0.1;16.36;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
653;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.117;-;12;39;50;764;19;49;0.38;19.59;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
654;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.117;Q4;19;71;350;968;30;343;0.08;13.63;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
655;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.116;Q4;17;50;93;1145;26;84;0.28;22.9;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Critical Care and Intensive Care Medicine (Q3); Cardiology and Cardiovascular Medicine (Q4); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
656;19700175049;Internet Journal of Toxicology;journal;15593916;0.116;Q4;7;3;38;111;14;38;0.37;37;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
657;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.116;Q4;5;11;44;160;4;43;0.13;14.55;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
658;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.115;Q4;9;0;189;0;15;181;0.07;0;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
659;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.115;Q4;6;0;6;0;2;6;0.33;0;Netherlands;Western Europe;;;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
660;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.115;Q4;9;20;42;410;10;42;0.1;20.5;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
661;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;-;0.114;-;5;0;71;0;11;70;0.15;0;United States;Northern America;;;"Molecular Medicine; Pharmacology"
662;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.114;Q4;12;110;244;1992;29;244;0.09;18.11;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
663;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.114;Q4;14;0;26;0;9;26;0;0;Germany;Western Europe;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
664;21716;Pharmazeutische Zeitung;journal;00317136;0.114;Q4;7;524;1470;782;7;762;0.01;1.49;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
665;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.113;Q4;10;44;39;2873;9;39;0.23;65.3;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
666;20572;PZ Prisma;journal;09455566;0.113;Q4;5;36;97;645;7;86;0.08;17.92;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
667;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.112;Q4;22;60;167;1289;4;167;0.02;21.48;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
668;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.112;Q4;5;26;143;875;7;139;0.07;33.65;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
669;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.112;Q4;10;0;22;0;4;21;0;0;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
670;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.111;Q4;3;24;107;181;2;94;0.01;7.54;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
671;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;-;0.111;-;5;0;221;0;8;216;0.04;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
672;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;18;24;72;823;3;72;0;34.29;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
673;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.111;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
674;23009;Journal of Clinical Research;journal;13695207;0.111;Q4;11;0;5;0;1;5;0;0;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
675;13000154717;Current Topics in Toxicology;journal;09728228;0.11;Q4;7;13;9;542;2;9;0.4;41.69;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
676;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.11;Q4;5;63;192;479;6;192;0.04;7.6;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
677;21798;Farmaceutski Glasnik;journal;00148202;0.11;Q4;6;64;233;729;2;190;0.01;11.39;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
678;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.109;Q4;14;19;13;529;2;13;0.15;27.84;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q4)
679;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.108;Q4;3;77;138;96;4;137;0.03;1.25;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
680;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.108;Q4;12;8;25;1218;2;19;0.08;152.25;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q4); Molecular Medicine (Q4)"
681;22887;Chinese Journal of Antibiotics;journal;10018689;0.107;Q4;11;174;554;2441;43;553;0.06;14.03;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
682;20628;Circular Farmaceutica;journal;00097314;0.107;Q4;3;29;110;391;1;97;0.01;13.48;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
683;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.107;Q4;13;32;34;710;4;34;0.12;22.19;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
684;22979;Journal of Applied Therapeutic Research;journal;10292659;0.107;Q4;8;12;30;238;3;30;0.06;19.83;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
685;13637;Manufacturing Chemist;trade journal;02624230;0.107;Q4;6;103;277;216;4;256;0.01;2.1;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
686;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.107;Q4;6;12;45;394;5;38;0.16;32.83;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;25197;Revista de Toxicologia (discontinued);journal;02127113;0.107;Q4;11;12;38;460;5;37;0.12;38.33;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
688;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.106;Q4;7;6;18;221;4;18;0.17;36.83;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;19700174922;Chinese Journal of New Drugs;journal;10033734;0.106;Q4;12;537;1270;7299;76;1270;0.05;13.59;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
690;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.106;Q4;14;41;162;645;10;162;0.07;15.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
691;21100804474;European Pharmaceutical Journal;journal;24536725;0.106;Q4;8;10;33;213;3;31;0.09;21.3;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
692;21867;Geneesmiddelenbulletin;journal;03044629;0.106;Q4;7;63;175;302;3;65;0.03;4.79;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
693;5800207507;Side Effects of Drugs Annual;book series;03786080;0.106;Q4;6;52;157;5441;4;53;0.02;104.63;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
694;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.105;Q4;14;18;55;706;8;55;0.14;39.22;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
695;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.105;Q4;5;104;326;1654;9;326;0.02;15.9;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
696;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;0.105;Q4;5;0;11;0;2;9;0;0;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
697;25196;Revista Brasileira de Toxicologia;journal;14152983;0.105;Q4;7;0;25;0;3;25;0.08;0;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
698;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;-;0.104;-;1;0;33;0;1;32;0.03;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
699;19700175108;Drug Delivery System;journal;18812732, 09135006;0.104;Q4;8;29;87;541;6;87;0.02;18.66;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
700;19700174925;European Pharmaceutical Review;trade journal;13608606;0.104;Q4;8;30;72;542;5;64;0.07;18.07;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
701;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;-;0.104;-;5;0;50;0;5;48;0.1;0;United States;Northern America;;;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
702;19700201410;Milestones in Drug Therapy;book series;22966056;0.104;Q4;5;18;41;1246;2;41;0.05;69.22;United States;Northern America;Springer Science + Business Media;2010-2017;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
703;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.104;Q4;19;0;9;0;1;8;0;0;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q4); Pharmacology (Q4)"
704;21823;Pharmacia;journal;04280296;0.104;Q4;16;16;34;308;4;34;0.05;19.25;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
705;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.104;Q4;10;29;84;265;3;83;0.02;9.14;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
706;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.103;Q4;8;19;56;402;5;49;0.08;21.16;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
707;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.103;Q4;9;0;7;0;2;7;0.29;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
708;21243;Pharmacy Times;trade journal;00030627;0.103;Q4;8;187;614;1027;16;549;0.02;5.49;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
709;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.103;Q4;2;0;7;0;0;7;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
710;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.103;Q4;39;0;6;0;0;6;0;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
711;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.102;Q4;6;25;16;471;3;12;0.19;18.84;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
712;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.102;Q4;19;31;63;772;3;63;0.05;24.9;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
713;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.102;Q4;3;3;12;103;0;12;0;34.33;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
714;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;36;107;0;3;107;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
715;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.101;Q4;11;8;29;89;2;22;0.05;11.13;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
716;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.101;Q4;11;0;65;0;1;65;0;0;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
717;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;0;25;0;0;22;0;0;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
718;19700171709;Arhiv za Farmaciju;journal;00041963;0.101;Q4;4;31;70;841;1;70;0.01;27.13;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
719;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;-;0.101;-;1;0;29;0;0;28;0;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
720;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;26;0;20;0;0;18;0;0;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
721;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;294;656;283;4;319;0;0.96;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
722;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.101;Q4;3;65;223;269;3;218;0.01;4.14;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
723;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.101;Q4;4;19;83;276;1;72;0.02;14.53;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
724;19500157008;Fooyin Journal of Health Sciences;journal;18778607, 18778615;0.101;Q4;6;0;35;0;5;33;0.14;0;Netherlands;Western Europe;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
725;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.101;Q4;1;0;18;0;0;16;0;0;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
726;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.101;Q4;7;101;332;780;5;320;0.01;7.72;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
727;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.101;Q4;25;41;69;542;2;69;0.03;13.22;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
728;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;7;261;788;3593;17;788;0.01;13.77;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
729;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.101;Q4;9;0;23;0;0;23;0;0;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
730;21077;Pharmaca;journal;00316857;0.101;Q4;5;19;44;258;3;34;0.08;13.58;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
731;20543;Pharmacometrics;journal;03008533;0.101;Q4;6;16;39;219;1;39;0.03;13.69;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
732;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;23;23;53;0;18;0;2.3;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
733;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.101;Q4;5;0;31;0;0;30;0;0;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
734;72755;Phytomedica;journal;09723293;0.101;Q4;4;0;14;0;0;14;0;0;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
735;17716;Quality Assurance Journal;journal;10991786, 10878378;0.101;Q4;9;13;32;163;5;29;0.16;12.54;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
736;16800154712;Sp2;trade journal;1476184X;0.101;Q4;2;51;138;28;1;124;0.01;0.55;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
737;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;-;0.1;-;5;0;53;0;3;50;0.06;0;United States;Northern America;;;"Molecular Medicine; Pharmacology"
738;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;-;0.1;-;0;0;44;0;0;42;0;0;United States;Northern America;;;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
739;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;3;19;54;254;2;54;0.04;13.37;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
740;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.1;Q4;4;157;249;264;6;200;0.02;1.68;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
741;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;42;146;35;1;123;0.01;0.83;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
742;19700174996;European Life Science Journal;trade journal;20001444;0.1;Q4;1;16;121;0;0;119;0;0;Norway;Western Europe;International Business Media AB;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
743;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.1;Q4;3;14;85;376;2;84;0.02;26.86;Poland;Eastern Europe;Grupa Dr. A. R. Kwiecinskiego;2010-2011;Pharmaceutical Science (Q4)
744;19700169211;Life Science Clusters;trade journal;17528119;0.1;Q4;0;0;71;0;0;65;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
745;19700175602;Next Generation Pharmaceutical;trade journal;-;0.1;Q4;1;31;190;0;0;132;0;0;United Kingdom;Western Europe;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
746;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135, 19363435;0.1;Q4;1;40;49;329;0;43;0;8.23;United States;Northern America;Wiley-Blackwell;2010-2012;Pharmaceutical Science (Q4)
747;21227;Pharmacy in Practice;journal;13581538;0.1;Q4;5;0;82;0;1;71;0;0;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
748;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;123;544;8;0;215;0;0.07;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
749;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;145;417;1971;130;405;0.24;13.59;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
750;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;;-;13;24;0;1039;0;0;0;43.29;Germany;Western Europe;Springer Verlag;2011, 2014-2021;Pharmaceutical Science
751;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;;-;42;14;0;404;0;0;0;28.86;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
752;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;;-;12;18;0;701;0;0;0;38.94;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery
753;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;;-;6;10;0;122;0;0;0;12.2;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
754;21100238633;BioImpacts;journal;22285652, 22285660;;-;37;35;0;1052;0;0;0;30.06;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmaceutical Science"
755;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;38;84;2420;193;83;2.32;63.68;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
756;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;;-;28;280;0;5330;0;0;0;19.04;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science
757;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;;-;46;46;0;1758;0;0;0;38.22;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science
758;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;30;81;1143;40;81;0.47;38.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
759;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;;-;16;21;1;525;0;1;0;25;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Analytical Chemistry; Electrochemistry; Pharmaceutical Science; Spectroscopy"
760;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254, 22114262;;-;7;19;0;679;0;0;0;35.74;Taiwan;Asiatic Region;Elsevier Taiwan LLC;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Biomedical Engineering; Drug Discovery; Medicine (miscellaneous)"
761;21100202747;GMP Review;trade journal;14764547;;-;2;17;0;46;0;0;0;2.71;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science
762;21100199794;Industrial Pharmacy;trade journal;17414911;;-;4;19;0;93;0;0;0;4.89;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science
763;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;;-;8;6;0;175;0;0;0;29.17;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Microbiology (medical); Pharmacology; Pharmacology (medical)"
764;19900192735;International Drug Discovery;journal;21504806, 21504792;;-;4;28;0;735;0;0;0;26.25;United States;Northern America;Russell Publishing LLC;2011-2012;Drug Discovery
765;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;;-;40;4;0;327;0;0;0;81.75;Netherlands;Western Europe;Elsevier BV;2011-2021;"Infectious Diseases; Parasitology; Pharmacology; Pharmacology (medical)"
766;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;;-;20;14;0;451;0;0;0;32.21;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science
767;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;;-;7;19;0;236;0;0;0;12.42;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011;Pharmaceutical Science
768;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;;-;15;63;0;1994;0;0;0;31.65;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science
769;20500195212;International Journal of Drug Delivery Technology;journal;09754415;;-;10;17;0;682;0;0;0;40.12;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science
770;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;;-;13;18;0;394;0;0;0;21.89;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Drug Discovery; Pharmaceutical Science; Pharmacology (medical)"
771;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;;-;7;2;0;33;0;0;0;16.5;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
772;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;;-;19;23;0;388;0;0;0;16.87;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery
773;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;;-;23;240;0;6273;0;0;0;26.14;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Biomedical Engineering; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
774;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;;-;10;6;0;176;0;0;0;29.33;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
775;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;;-;41;326;0;8387;0;0;0;25.73;India;Asiatic Region;MediPoeia;2011-2021;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
776;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;;-;12;58;0;1352;0;0;0;23.31;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science
777;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;37;0;1204;0;0;0;32.54;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
778;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;;-;39;634;0;14513;0;0;0;22.89;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science
779;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;;-;13;81;0;1807;0;0;0;22.31;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science
780;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;36;76;642;9;76;0.16;17.83;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
781;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;12;71;349;7;71;0.1;29.08;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
782;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;;-;38;40;0;979;0;0;0;24.48;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Analytical Chemistry; Drug Discovery; Electrochemistry; Pharmaceutical Science; Pharmacy; Spectroscopy"
783;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;;-;42;89;0;3272;0;0;0;36.76;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Bioengineering; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
784;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;;-;12;27;0;811;0;0;0;30.04;Canada;Northern America;;2011-2021;"Health (social science); Medicine (miscellaneous); Nutrition and Dietetics; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
785;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;;-;7;28;0;282;0;0;0;10.07;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine; Toxicology"
786;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;22;22;693;21;22;0.95;31.5;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
787;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;;-;24;7;0;160;0;0;0;22.86;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
788;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;330;473;4699;189;473;0.32;14.24;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
789;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;;-;13;16;0;296;0;0;0;18.5;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Physiology"
790;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;25;0;646;0;0;0;25.84;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
791;21100451405;Natural Products Journal;journal;22103163, 22103155;;-;13;18;0;728;0;0;0;40.44;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine; Drug Discovery"
792;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;12;3;0;0;2;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
793;19700201509;Pharma Research (discontinued);journal;09758216;;-;5;46;0;1208;0;0;0;26.26;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;23;64;2121;115;64;1.83;92.22;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
795;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;;-;47;399;0;8587;0;0;0;21.52;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
796;19900192163;Results in Pharma Sciences;journal;22112863;;-;16;11;0;385;0;0;0;35;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science
797;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;171;48;6313;129;45;2.69;36.92;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
798;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;;-;6;35;0;814;0;0;0;23.26;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering; Drug Discovery"
799;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;;-;9;26;0;469;0;0;0;18.04;Bangladesh;Asiatic Region;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science
800;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;;-;18;50;0;1311;0;0;0;26.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science; Statistics and Probability"
801;21100787110;Therapeutic Advances in Psychopharmacology;journal;20451261, 20451253;;-;26;26;0;817;0;0;0;31.42;United States;Northern America;SAGE Publications Inc.;2011-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychology (miscellaneous)"
802;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;;-;3;62;0;1137;0;0;0;18.34;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
803;21100376682;Toxicologie Analytique et Clinique;journal;23520078;;-;9;31;0;667;0;0;0;21.52;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis; Toxicology"
